Product Name :
Lujo mammarenavirus Nucleocapsid Protein（LUJV） Background :
Lujo virus (LUJV), a new member of the family Arenaviridae and the first hemorrhagic fever associated arenavirus from the Old World discovered in three decades, was isolated in South Africa during an outbreak of human disease characterized by nosocomial transmission and an unprecedented high case fatality rate of 80% (4/5 cases). Full genome analyses of LUJV showed it to be unique and branching off the ancestral node of the Old World arenaviruses. The virus G1 glycoprotein sequence was highly diverse and almost equidistant from that of other Old World and New World arenaviruses, consistent with a potential distinctive receptor tropism. LUJV is a novel, genetically distinct, highly pathogenic arenavirus. Product :
Inclusion body;0.5mol Urea,PH=8 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
Carrier: pET30a-LUJV-NP-His(C-term) Virus: Lujo virus segment S Immunogen :
pathway :

• 
  Lujo mammarenavirus Nucleocapsid Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.

Blocking peptide available as NCP0135P